Previous studies have demonstrated that hibernating myocardium can be assessed by [18F]fluorodeoxyglucose ([18F]FDG) and positron emission tomography (PET). This study evaluated the use of [18F]FDG-PET for CABG related risk assessment in patients with coronary artery disease (CAD) and left ventricle dysfunction (LVD).
Assessment of CABG-related risk in patients with CAD and LVD. Contribution of PET with [18F]FDG to the assessment of myocardial viability / C. Landoni, G. Lucignani, G. Paolini, M. Zuccari, L. Galli, G. Di Credico, C. Rossetti, S. Pelenghi, M. C. Gilardi, F. Fazio, A. Grossi. - In: JOURNAL OF CARDIOVASCULAR SURGERY. - ISSN 0021-9509. - 40:3(1999 Jun), pp. 363-72-372.
Assessment of CABG-related risk in patients with CAD and LVD. Contribution of PET with [18F]FDG to the assessment of myocardial viability
G. Lucignani;L. Galli;
1999
Abstract
Previous studies have demonstrated that hibernating myocardium can be assessed by [18F]fluorodeoxyglucose ([18F]FDG) and positron emission tomography (PET). This study evaluated the use of [18F]FDG-PET for CABG related risk assessment in patients with coronary artery disease (CAD) and left ventricle dysfunction (LVD).
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
